Is Vera Therapeutics, Inc. overvalued?

Vera Therapeutics, Inc. (VERA) — key valuation metrics and fundamentals.

No verdict

Price

$28.10

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.03B

Dividend yield

0.0%

Return on equity

-90.0%

Sector

Healthcare

Fair value compares VERA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks